What to watch with CYP2C19 and skin aging?

CYP2C19 is a drug-metabolizing enzyme primarily involved in processing medications like clopidogrel, proton pump inhibitors, and certain antidepressants. There is no established direct link between CYP2C19 variants and skin aging. Any connection would be indirect, possibly through metabolism of endogenous compounds or drugs that affect skin health, but this remains speculative. Skin aging is mainly driven by UV exposure, oxidative stress, collagen degradation, and genetic factors such as MC1R or collagen-related genes. A DNA test for CYP2C19 does not provide meaningful insights into skin aging. For skin health, focus on sun protection, antioxidants, and a balanced diet. The evidence for a CYP2C19–skin aging association is unclear and not supported by robust studies.